Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

STOK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $70,209,310.82

Stoke Therapeutics Insider Trading History Chart

Stoke Therapeutics Share Price & Price History

^$11.68

▲ +0.38 (3.36%)

As of 12/20/2024 06:31 PM ET

Days: 30 | 90 | 365

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry.

Stoke Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/9/2024	Barry Ticho	Insider	Sell	2,586	$12.99	$33,592.14	44,746
12/9/2024	Edward M Md Kaye	CEO	Sell	6,786	$12.99	$88,150.14	61,885
12/9/2024	Jonathan Allan	General Counsel	Sell	13,666	$13.61	$185,994.26	21,476
12/6/2024	Barry Ticho	Insider	Sell	13,945	$12.78	$178,217.10	47,332
12/6/2024	Edward M Md Kaye	CEO	Sell	6,170	$12.78	$78,852.60	68,671
12/6/2024	Jonathan Allan	General Counsel	Sell	9,696	$12.78	$123,914.88	35,142
12/2/2024	Barry Ticho	Insider	Sell	10,000	$12.07	$120,700.00	51,277
9/19/2024	Skorpios Trust	Major Shareholder	Sell	1,937,500	$14.05	$27,221,875.00	8,906,181
7/1/2024	Barry Ticho	Insider	Sell	10,000	$13.75	$137,500.00	2,485
4/17/2024	Skorpios Trust	Major Shareholder	Sell	3,600,000	$11.60	$41,760,000.00	10,843,681
3/28/2024	Jonathan Allan	General Counsel	Sell	5,126	$13.20	$67,663.20	2,598
3/19/2024	Edward M Md Kaye	CEO	Sell	11,150	$6.10	$68,015.00	69,350
3/19/2024	Jonathan Allan	General Counsel	Sell	2,349	$6.10	$14,328.90	7,724
3/19/2024	Stephen J Tulipano	CFO	Sell	4,116	$6.10	$25,107.60	20,746
2/1/2024	Barry Ticho	Insider	Sell	10,000	$4.80	$48,000.00	6,981
1/2/2024	Barry Ticho	Insider	Sell	10,000	$5.74	$57,400.00	16,981
7/3/2023	Barry Ticho	Insider	Sell	15,000	$10.60	$159,000.00	25,895
6/21/2023	Jonathan Allan	General Counsel	Sell	1,948	$13.48	$26,259.04
6/1/2023	Barry Ticho	Insider	Sell	15,000	$11.13	$166,950.00	40,895
5/3/2023	Barry Ticho	Insider	Sell	24,697	$10.14	$250,427.58	56,548
5/1/2023	Barry Ticho	Insider	Sell	24,967	$10.00	$249,670.00	86,758
2/6/2023	Barry Ticho	Insider	Sell	9,235	$10.02	$92,534.70	111,725
2/2/2023	Barry Ticho	Insider	Sell	267	$10.00	$2,670.00	124,723
1/31/2023	Barry Ticho	Insider	Sell	200	$10.00	$2,000.00	130,695
1/3/2022	Huw M. Nash	COO	Sell	3,800	$23.07	$87,666.00

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

SEC Filings (Institutional Ownership Changes) for Stoke Therapeutics (NASDAQ:STOK)

Institutional Buying and Selling by Quarter

Stoke Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/13/2024	Exome Asset Management LLC	176,600	$2.17M	1.5%	N/A	0.333%
11/27/2024	Franklin Resources Inc.	22,314	$0.29M	0.0%	-98.2%	0.042%
11/19/2024	Barclays PLC	79,740	$0.98M	0.0%	+145.3%	0.151%
11/16/2024	Geode Capital Management LLC	870,831	$10.71M	0.0%	+9.7%	1.644%
11/15/2024	Barclays PLC	79,740	$0.98M	0.0%	+145.3%	0.151%
11/15/2024	Jane Street Group LLC	330,442	$4.06M	0.0%	+338.2%	0.624%
11/15/2024	Wellington Management Group LLP	136,975	$1.68M	0.0%	-4.6%	0.259%
11/15/2024	State Street Corp	1,728,888	$21.25M	0.0%	+8.6%	3.264%
11/15/2024	RTW Investments LP	4,652,285	$57.18M	0.8%	+10.1%	8.783%
11/15/2024	Redmile Group LLC	4,713,509	$57.93M	3.4%	-0.2%	8.898%
11/15/2024	Checkpoint Capital L.P.	157,514	$1.94M	1.0%	N/A	0.297%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	42,692	$0.53M	0.0%	-25.6%	0.081%
11/13/2024	BNP Paribas Financial Markets	76,154	$0.94M	0.0%	+1,589.7%	0.144%
11/13/2024	FMR LLC	322,949	$3.97M	0.0%	-18.9%	0.610%
11/12/2024	Charles Schwab Investment Management Inc.	316,134	$3.89M	0.0%	+9.3%	0.597%
11/9/2024	Intech Investment Management LLC	13,052	$0.16M	0.0%	N/A	0.025%
11/4/2024	Los Angeles Capital Management LLC	103,005	$1.27M	0.0%	+54.3%	0.196%
11/2/2024	Mesirow Financial Investment Management Inc.	15,604	$0.19M	0.0%	N/A	0.030%
10/23/2024	Skorpios Trust	8,906,181	$109.46M	99.8%	-17.9%	16.916%
10/23/2024	Assenagon Asset Management S.A.	1,312,479	$16.13M	0.0%	-10.6%	2.493%
10/3/2024	SG Americas Securities LLC	14,917	$0.18M	0.0%	-78.3%	0.029%
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	1,387,200	$18.74M	0.1%	+426.1%	2.635%
9/4/2024	Ghisallo Capital Management LLC	15,000	$0.20M	0.0%	-50.0%	0.028%
8/15/2024	Lynx1 Capital Management LP	5,185,191	$70.05M	25.3%	+40.3%	9.848%
8/15/2024	The Manufacturers Life Insurance Company	13,964	$0.19M	0.0%	+16.7%	0.027%
8/15/2024	Millennium Management LLC	289,067	$3.91M	0.0%	+528.6%	0.549%
8/14/2024	Squarepoint Ops LLC	15,042	$0.20M	0.0%	-70.6%	0.029%
8/14/2024	Marshall Wace LLP	1,161,037	$15.69M	0.0%	+550.1%	2.205%
8/14/2024	Logos Global Management LP	1,050,000	$14.19M	1.1%	N/A	1.994%
8/14/2024	Profund Advisors LLC	14,893	$0.20M	0.0%	N/A	0.028%
8/9/2024	Renaissance Technologies LLC	11,200	$0.15M	0.0%	-41.4%	0.021%
8/9/2024	Dimensional Fund Advisors LP	191,360	$2.59M	0.0%	-12.9%	0.367%
8/8/2024	American Century Companies Inc.	59,149	$0.80M	0.0%	+99.4%	0.113%
8/6/2024	Quest Partners LLC	2,110	$29K	0.0%	N/A	0.004%
8/6/2024	Los Angeles Capital Management LLC	66,765	$0.90M	0.0%	+7.2%	0.128%
8/1/2024	Rhumbline Advisers	47,860	$0.65M	0.0%	+14.3%	0.092%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	9,129	$0.12M	0.0%	N/A	0.018%
7/26/2024	Bank of New York Mellon Corp	115,892	$1.57M	0.0%	+28.9%	0.222%
7/20/2024	Nisa Investment Advisors LLC	2,989	$40K	0.0%	+53.2%	0.006%
7/18/2024	Assenagon Asset Management S.A.	1,468,202	$19.84M	0.0%	N/A	2.817%
7/12/2024	SG Americas Securities LLC	68,601	$0.93M	0.0%	+610.3%	0.132%
5/30/2024	Lynx1 Capital Management LP	3,696,820	$49.91M	12.9%	+25.0%	7.093%
5/17/2024	Artal Group S.A.	300,000	$4.05M	0.1%	N/A	0.576%
5/17/2024	Ikarian Capital LLC	6,816	$92K	0.0%	-43.7%	0.013%
5/16/2024	California State Teachers Retirement System	2,803	$38K	0.0%	-38.3%	0.005%
5/16/2024	Jacobs Levy Equity Management Inc.	47,912	$0.65M	0.0%	-71.5%	0.092%
5/16/2024	Redmile Group LLC	5,073,049	$68.49M	2.5%	+93.2%	9.733%
5/15/2024	Baker BROS. Advisors LP	3,368,443	$45.47M	0.6%	+65.9%	6.463%
5/15/2024	Price T Rowe Associates Inc. MD	31,431	$0.43M	0.0%	+5.5%	0.060%
5/15/2024	Lazard Asset Management LLC	3,710	$49K	0.0%	-35.8%	0.007%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	263,700	$3.56M	0.0%	+10.2%	0.506%
5/10/2024	Vanguard Group Inc.	1,715,554	$23.16M	0.0%	+4.1%	3.292%
5/9/2024	State Board of Administration of Florida Retirement System	10,473	$0.14M	0.0%	N/A	0.020%
5/7/2024	Susquehanna Portfolio Strategies LLC	43,424	$0.59M	0.0%	-3.7%	0.083%
5/7/2024	SG Americas Securities LLC	9,658	$0.13M	0.0%	-36.0%	0.019%
5/3/2024	GSA Capital Partners LLP	97,508	$1.32M	0.1%	-4.5%	0.187%
5/2/2024	Chase Investment Counsel Corp	20,738	$0.28M	0.1%	N/A	0.040%
5/1/2024	BNP Paribas Financial Markets	14,330	$0.19M	0.0%	+86.2%	0.027%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	90,663	$1.22M	0.0%	N/A	0.174%
4/29/2024	Principal Financial Group Inc.	10,451	$0.14M	0.0%	-13.2%	0.020%
4/23/2024	Seven Grand Managers LLC	30,000	$0.41M	0.2%	N/A	0.065%
2/15/2024	Birchview Capital LP	210,000	$1.11M	0.9%	+147.1%	0.470%
2/14/2024	RTW Investments LP	4,131,045	$21.73M	0.3%	-5.9%	9.252%
2/9/2024	Trexquant Investment LP	39,800	$0.21M	0.0%	-68.8%	0.089%
2/6/2024	Los Angeles Capital Management LLC	62,257	$0.33M	0.0%	+30.4%	0.139%
2/2/2024	Simplex Trading LLC	7,979	$41K	0.0%	-35.0%	0.018%
12/19/2023	Public Employees Retirement System of Ohio	16,335	$64K	0.0%	N/A	0.037%
11/15/2023	GSA Capital Partners LLP	348,069	$1.37M	0.1%	+514.7%	0.780%
11/15/2023	Redmile Group LLC	3,872,696	$15.26M	0.7%	-2.1%	8.673%
11/14/2023	Corton Capital Inc.	14,749	$58K	0.0%	N/A	0.033%
11/14/2023	Sherbrooke Park Advisers LLC	12,295	$48K	0.0%	N/A	0.028%
11/14/2023	Lynx1 Capital Management LP	1,710,154	$6.74M	4.5%	N/A	3.830%
11/14/2023	Trexquant Investment LP	127,581	$0.50M	0.0%	+166.9%	0.286%
11/13/2023	Algert Global LLC	16,550	$65K	0.0%	-52.5%	0.037%
11/13/2023	Healthcare of Ontario Pension Plan Trust Fund	239,300	$0.94M	0.0%	-15.1%	0.536%
11/8/2023	Dorsey & Whitney Trust CO LLC	10,815	$43K	0.0%	N/A	0.024%
11/7/2023	Barclays PLC	8,440	$33K	0.0%	-43.1%	0.019%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	146,076	$0.58M	0.0%	+9.3%	0.330%
10/24/2023	Bank of New York Mellon Corp	107,254	$0.42M	0.0%	+2.8%	0.242%
10/13/2023	SG Americas Securities LLC	13,557	$53K	0.0%	N/A	0.031%
9/21/2023	Barclays PLC	14,829	$0.16M	0.0%	-35.1%	0.034%
8/14/2023	Driehaus Capital Management LLC	102,489	$1.09M	0.0%	N/A	0.232%
8/14/2023	Granahan Investment Management LLC	532,880	$5.67M	0.2%	-11.7%	1.204%
8/11/2023	M28 Capital Management LP	346,190	$3.68M	4.9%	-35.0%	0.782%
8/11/2023	Trexquant Investment LP	47,796	$0.51M	0.0%	-62.0%	0.108%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	133,598	$1.42M	0.0%	+44.7%	0.302%
8/7/2023	Principal Financial Group Inc.	11,388	$0.12M	0.0%	N/A	0.026%
8/7/2023	Cowen AND Company LLC	3,721,659	$39.56M	3.3%	+13.5%	8.422%
8/4/2023	American International Group Inc.	13,277	$0.14M	0.0%	+22.6%	0.030%
8/3/2023	Los Angeles Capital Management LLC	49,077	$0.52M	0.0%	+25.7%	0.111%
5/16/2023	Baker BROS. Advisors LP	2,115,416	$17.62M	0.1%	+90.8%	4.787%
5/15/2023	RTW Investments LP	4,390,558	$36.57M	0.8%	+13.4%	9.936%
5/15/2023	Granahan Investment Management LLC	603,524	$5.03M	0.2%	+9.7%	1.366%
5/10/2023	Simplify Asset Management Inc.	122,796	$1.02M	0.1%	N/A	0.278%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	51,935	$0.43M	0.0%	-7.5%	0.118%
5/9/2023	Cowen AND Company LLC	3,279,142	$27.32M	3.2%	+338.3%	7.421%
5/4/2023	Los Angeles Capital Management LLC	39,055	$0.33M	0.0%	-3.4%	0.088%
2/14/2023	Granahan Investment Management LLC	550,219	$5.08M	0.2%	+112.4%	1.396%
2/13/2023	GSA Capital Partners LLP	71,572	$0.66M	0.1%	-4.7%	0.182%
2/10/2023	M28 Capital Management LP	482,890	$4.46M	4.2%	-7.6%	1.225%

Data available starting January 2016

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary targeted augmentation of nuclear gene output to develop antisense oligonucleotides to selectively restore protein levels. Its lead clinical candidate is STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. The company also develops STK-001, which is in phase I/II clinical trial to treat Dravet syndrome; and programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye. The company has a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $11.68

$10.81

$11.84

50 Day Range

MA: $12.48

$11.11

$13.92

52 Week Range

Now: $11.68

$4.09

$17.58

Volume

1,156,170 shs

Average Volume

744,608 shs

Market Capitalization

$618.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Stoke Therapeutics?: Stoke Therapeutics' top insider shareholders include:
Skorpios Trust (Major Shareholder)
Barry Ticho (Insider)
Edward M Md Kaye (CEO)
Jonathan Allan (General Counsel)
Stephen J Tulipano (CFO)
Learn More about top insider investors at Stoke Therapeutics.
Who are the major institutional investors of Stoke Therapeutics?: Stoke Therapeutics' top institutional shareholders include:
Skorpios Trust — 16.92%
Redmile Group LLC — 8.90%
RTW Investments LP — 8.78%
State Street Corp — 3.26%
Assenagon Asset Management S.A. — 2.49%
Geode Capital Management LLC — 1.64%
Learn More about top institutional investors of Stoke Therapeutics stock.
Which institutional investors are selling Stoke Therapeutics stock?: During the last quarter, STOK stock was sold by these institutional investors:
Skorpios Trust
Franklin Resources Inc.
Assenagon Asset Management S.A.
FMR LLC
SG Americas Securities LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Redmile Group LLC
Wellington Management Group LLP
During the last year, company insiders that have sold Stoke Therapeutics company stock include:
Skorpios Trust (Major Shareholder)
Barry Ticho (Insider)
Edward M Md Kaye (CEO)
Jonathan Allan (General Counsel)
Stephen J Tulipano (CFO)
Learn More investors selling Stoke Therapeutics stock.
Which institutional investors are buying Stoke Therapeutics stock?: In the last quarter, STOK stock was purchased by institutional investors including:
RTW Investments LP
Jane Street Group LLC
Exome Asset Management LLC
Checkpoint Capital L.P.
State Street Corp
Geode Capital Management LLC
BNP Paribas Financial Markets
Barclays PLC